Rodman & Renshaw Downgrades Interleukin Genetics (ILIU) to Market Perform
Tweet
Share
E-mailGet Alerts ILIU Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw downgraded Interleukin Genetics (OTC: ILIU) from Market Outperform to Market Perform.
For more ratings news on Interleukin Genetics click here and for the rating history of Interleukin Genetics click here.
Shares of Interleukin Genetics closed at $0.46 yesterday.
For more ratings news on Interleukin Genetics click here and for the rating history of Interleukin Genetics click here.
Shares of Interleukin Genetics closed at $0.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- JPMorgan Downgrades KinderCare Learning Companies (KLC) to Underweight
- Wolfe Research Downgrades T-Mobile (TMUS) to Peerperform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
